ExpreS2ion to present in investor and R&D events in March
Hørsholm, Denmark, 29 February 2024 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") will participate in investor and R&D events during March.By attending relevant industry and investor events, the company aims to increase the awareness of its technology platform and its exciting development pipeline. More information on each event and how to register is found below and on the Company’s website . 5 March 2024 | Aktiespararna Stora Aktiedagarna13:30 CET | Stockholm, SwedenJoin CEO Bent Frandsen for a live